Organization Profile

You just read:

Eisai receives Health Canada approval for antiepileptic agent FYCOMPA® as adjunctive treatment for patients with primary generalized tonic-clonic seizures

News provided by

Eisai Limited

Dec 03, 2015, 08:25 ET